We\'re Hub Innovations, a consumer products company born with the mission of developing unique, innovative products that enhance the user\'s experience with their mobile devices. Design, functionality and simplicity is what we live by.
From cell phones to tablets and everything in between, Hub Innovations is focused on developing solutions to help consumers run their personal and professional lives more efficiently. From running a fast-growing national distributor of high quality agrochemicals to pioneering nation-wide retail vaccination programs.
Sling Media, Inc., a wholly owned subsidiary of EchoStar Corporation (NASDAQ: SATS), today announced the Slingbox® M1 and SlingTV™, replacing the popular and award-winning Slingbox 350 and 500 models. Both of these retail products are the only solutions capable of delivering a customer’s pay TV channels and programs (live or recorded) from the living room to the most popular mobile devices in up to HD quality with no restrictions. In addition SlingTV delivers the power of a Slingbox combined with new “Smarter TV” features designed to enhance the TV viewing experience in the living room.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7272751-slingbox-m1-slingtv-tv-anywhere-mobile-device-smart-living-room-tv-experience/
Lucky Charms™ cereal is launching its second annual #LuckyToBe campaign, celebrating individuality, diversity and inclusiveness. The magically delicious cereal brand is encouraging fans everywhere to share why they are #LuckyToBe.
“We are honoring everything that makes each of us special and adds color to our world — just like the marshmallow charms in our cereal,” said Michael Lenahan, associate marketing manager for Lucky Charms. “We are celebrating everyone who is proud to live life on their own terms and love every second of it.”
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7235651-general-mills-lucky-charms-second-annual-luckytobe-campaign
During a live global event, Elekta announced the launch of Versa HD™, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of cancers. Featuring high precision beam shaping and tumor targeting, Versa HD also unveils new capabilities designed to maximize health care system resources and deliver highly sophisticated therapies without compromising treatment times.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60246-elekta-sets-new-benchmark-for-cancer-treatment-launch-of-versa-hd-system
Summer road trip season is here, so grab the family and pack up the car! There is a richness to making your way across a state or country by car that is absent from the experience of boarding a metal bird and climbing out at your destination. Whether you’re going on a short trip or a cross-country adventure proper preparation is a must.
Travel and lifestyle expert, Amy Goodman, is available for live interviews on XXXX ##, 2016 to discuss her tips and tricks to make your summer road trip one to remember. From what to pack to where pull over for a bite to eat she’ll make prepping for your vacation quick and simple.
Take a spin in the signature Coach Chairs, record an audition demo on the spot and soak in live performances from some of the most electrifying singers ever to hit NBC’s THE VOICE in a brand new musical concert experience as THE VOICE: NEON DREAMS opens this spring at Hard Rock Hotel & Casino. Tickets for performances beginning in spring 2018 are on sale now and can be purchased at TheVoiceVegas.com.
An innovative concert experience, THE VOICE: NEON DREAMS is the continuation of the musical journey for some of the show’s hottest contestants, bringing fans up close to their favorite performers and right into the world of THE VOICE, allowing them, through a unique and interactive pre-show experience, to take the first steps on their very own VOICE journey.
To view the multimedia release go to:
https://www.multivu.com/players/English/8212151-the-voice-neon-dreams-hard-rock-hotel-casino/
NFL PLAY 60, the National Football League’s youth health and fitness campaign, is the new “Official Champion of Play” at St. Jude Children’s Research Hospital®, the global leader in finding cures and saving children with cancer and other deadly diseases.
To commemorate this new milestone in the ongoing partnership between the NFL and St. Jude, a St. Jude patient will join NFL commissioner Roger Goodell on stage to announce a pick during the first round of the 2013 NFL Draft. The NFL Network and ESPN will televise live coverage of the NFL Draft beginning at 8 p.m. EST on Thursday, April 25.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58566-st-jude-children-s-research-hospital-nfl-play-60
CPhI Worldwide, part of UBM Live’s Pharmaceutical Portfolio, today celebrates its 25th birthday by releasing the first in a series of ‘made at CPhI’ pharma stories. These will follow 25 pharma industry successes that have directly resulted from meetings at CPhI. The first story charts Global Pharmaceutical Relief from a first meeting at CPhI only two years ago to today and providing hundreds of millions of dollars worth of medicines to the developing world via NGOs- not just another business story, but a great example of the CPhI family helping to proliferate healthcare throughout the globe.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762554-cphi-worldwide-celebrates-25-years/
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
